Liver (hepatocellular) cancer is one of the most common cancers worldwide. Between 500,000 and 650,000 new cases will be diagnosed each year. In the United States, the incidence of liver cancer is estimated to be between 10,000 and 15,000 cases per year. It is also rising, both in the United States. Globally, liver cancer is the 6th most common cancer in incidence but represents the 3rd largest by deadliness. As such, liver cancer is a global problem and new treatments are desperately needed.
The Approach - Networks of Excellence Model
For those patients who have incurable, generally fatal diseases, their best chance of success lies in receiving treatment at a center of excellence. This premise is even more attractive if they have a somewhat rare/uncommon disease (in Western countries) such as liver cancer (hepatocellular cancer). Due to the fragmented, multi-payer, insurance dominated health care system that exists in the United States, patients are unable to receive care that is at the cutting edge of what science and clinical research can potentially provide them.
At the Liver Cancer Research Network (LCRN), we have embraced the NETWORK OF EXCELLENCE Model to rapidly connect scientists/investigators, patients and sponsors who are interested in finding a cure for liver cancer.
0 comments:
Post a Comment